what states have banned semaglutide Medicare is expanding access to weight-loss GLP-1 medications. Starting July 1, eligible Medicare beneficiaries can receive GLP-1 prescriptions for obesity for $50 a month through a new federal pilot program, even without Weight-loss drugs will no longer

Lately, some reports are suggesting possible links between use of semaglutide in non-diabetics to kidney or heart damageissues the drugs were shown to actually help persons with diabetes avoid

Ruhoy said she is more excited about this class of drugs than any she can remember, and Kaufman agreed, stating that hed even dreamt about them

Such databases collect what people report, and cannot separate cause from coincidence

Jan 22, 2026 Semaglutide and Heart Risk: What the Research Shows Can Ozempic (semaglutide) reduce cardiovascular risk

Embrace the power of GHK-CU and take the first step towards rejuvenating your hair

Porro, C